ACE-Inhibitor Therapy
Research from C. Kojima and co-researchers in the area of ACE-Inhibitor therapy published
Published in Cardiovascular Week, April 12th, 2010
"To investigate the contribution of ACEIs to foam cell formation, we studied the effects of an ACEI, imidaprilat, on THP-1 macrophages and the underlying molecular mechanisms in vitro. Pre-treatment of THP-1 macrophages with imidaprilat (100 nmol/L, 4 hours) significantly decreased foam cell formation induced by oxidized LDL (OxLDL). Imidaprilat reduced the protein level of MMP-9 in THP-1 macrophages and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2010-04-12)
More Articles from Cardiovascular Week
- HealthStar Pr
The creative engagement and cardiac health connection disclosed - Karolinska Institutet
How muscle cells control fatty acid uptake - Society of Nuclear Medicine
Matters of the heart: FDG PET may hold answers for patients with heart failure - University of California - Los Angeles
Study IDs medical conditions that put seniors at risk of falling into Medicare 'donut hole' - Abdominal Aortic Aneurysm
Study results from B.B. Yeap and colleagues broaden understanding of abdominal aortic aneurysm - Acute Hepatotoxicity
Researchers from Chinese Academy of Medical Science report on findings in acute hepatotoxicity - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
